机译:治疗响应和药物保留率在195年的轴向脊椎炎,发起TNFI治疗:来自12名注册管理机构的常规护理数据在EUROSPA合作中
EuroSpA Coordinating Center Copenhagen Center for Arthritis Research (COPECARE) Center for;
EuroSpA Coordinating Center Copenhagen Center for Arthritis Research (COPECARE) Center for;
Clinical Epidemiology Division Department of Medicine SolnaKarolinska Institutet;
Department of RheumatologyZurich University Hospital;
Institute of Rheumatology Department of Rheumatology 1st Faculty of MedicineCharles University;
TURKBIO Registry Division of RheumatologySchool of Medicine Dokuz Eylul University Izmir;
NOR-DMARD Registry Department of RheumatologyDiakonhjemmet Hospital;
ROB-FIN RegistryHelsinki University and Helsinki University Hospital;
Reuma.pt registry and Instituto de Medicina Molecular Faculdade de MedicinaUniversidade de Lisboa;
Department of RheumatologyRRBR Registry and University of Medicine and Pharmacy “Carol Davila”;
Research UnitSpanish Society of Rheumatology;
Department of RheumatologyUniversity Medical Centre Ljubljana;
Centre for Rheumatology Research (ICEBIO) University Hospital and Faculty of MedicineUniversity of;
Clinical Epidemiology Division Department of Medicine SolnaKarolinska Institutet;
Department of RheumatologyGeneva University Hospital;
Institute of Rheumatology Department of Rheumatology 1st Faculty of MedicineCharles University;
TURKBIO Registry Division of RheumatologySchool of Medicine Dokuz Eylul University Izmir;
NOR-DMARD Registry Department of RheumatologyDiakonhjemmet Hospital;
Inflammation Center Department of RheumatologyHelsinki University Hospital;
Rheuma.pt registry Rheumatology Department - Centro Hospitalar do Baixo Vouga and IbimedInstitute;
Department of RheumatologyRRBR Registry and University of Medicine and Pharmacy “Carol Davila”;
Research UnitSpanish Society of Rheumatology;
Department of RheumatologyUniversity Medical Centre Ljubljana;
Department of RheumatologyUniversity Hospital of Iceland Reykjavik;
DANBIO Registry Center for Rheumatology and Spine Diseases Centre for Head and;
Amsterdam UMC Department of RheumatologyVU University Medical Centre Amsterdam;
Epidemiology Group School of MedicineMedical Science and Nutrition University of Aberdeen;
GISEA Registry Rheumatology Unit – DETOUniversity of Bari;
EuroSpA Coordinating Center Copenhagen Center for Arthritis Research (COPECARE) Center for;
Zitelabs Aps;
EuroSpA Coordinating Center Copenhagen Center for Arthritis Research (COPECARE) Center for;
EuroSpA Coordinating Center Copenhagen Center for Arthritis Research (COPECARE) Center for;
spondyloarthritis; anti-TNF; epidemiology; outcomes research; DMARDS (biologic);
机译:治疗响应和药物保留率在195年的轴向脊椎炎,发起TNFI治疗:来自12名注册管理机构的常规护理数据在EUROSPA合作中
机译:为伴随轴向脊椎关节炎的患者定义最佳转诊策略:真正重要的是什么? 回应:'评估慢性低腰疼痛患者轴向脊椎关节炎早期推荐的ASAS建议; 是一个参数,足以用于初级保健练习吗?' 由van hoeven等
机译:Rhumadata临床数据库和注册中心中的强直性脊柱炎(AS)患者的TNF抑制剂(TNFi)保留率
机译:利用大数据和医疗信息学开发和测试终末期肾病患者不遵守肾脏替代治疗方案的预测模型
机译:在 中美 关于 药物 治疗依从性 和非药物 医疗利用 成本控制策略 的影响 和 成本 在 乳腺癌患者
机译:1860例轴向脊椎关节炎患者的药物保留非活性疾病和反应率发起Secukinumab治疗:来自Unspa合作中的13名注册管理机构的常规护理数据
机译:1860例轴向脊椎关节炎患者的药物保留,非活性疾病和反应率,发起Secukinumab治疗:来自Unspa合作中的13名注册管理机构的常规护理数据